Rossi, J.-F.; Bonnet, E.; Castelli, C.; Velensek, M.; Wisniewski, E.; Heraud, S.; Boustany, R.; David, C.; Dinet, J.; Sicard, R.;
et al. Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study. Vaccines 2023, 11, 493.
https://doi.org/10.3390/vaccines11030493
AMA Style
Rossi J-F, Bonnet E, Castelli C, Velensek M, Wisniewski E, Heraud S, Boustany R, David C, Dinet J, Sicard R,
et al. Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study. Vaccines. 2023; 11(3):493.
https://doi.org/10.3390/vaccines11030493
Chicago/Turabian Style
Rossi, Jean-François, Emmanuel Bonnet, Christel Castelli, Marion Velensek, Emma Wisniewski, Sophie Heraud, Rania Boustany, Céleste David, Jérôme Dinet, Roland Sicard,
and et al. 2023. "Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study" Vaccines 11, no. 3: 493.
https://doi.org/10.3390/vaccines11030493
APA Style
Rossi, J.-F., Bonnet, E., Castelli, C., Velensek, M., Wisniewski, E., Heraud, S., Boustany, R., David, C., Dinet, J., Sicard, R., Daures, J.-P., Bonifacy, M., Mousset, L., & Goffart, E.
(2023). Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study. Vaccines, 11(3), 493.
https://doi.org/10.3390/vaccines11030493
